Search Results 351-360 of 17106 for pharmacogenetics
Pharmacoexposomics is an emerging field of research focused on understanding how environmental exposures influence a person's response to medication. This new " ...
View clinical trials, clinical studies and funding information for Mayo Clinic's Genomic and Exposomic Hepatobiology Lab led by Konstantinos N. Lazaridis, ...
Veliparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as carboplatin, work in ...
View patient resources recommended by the Immuno-Epigenetics Lab led by William A. Faubion Jr., M.D., at Mayo Clinic's campus in Minnesota.
Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has ...
The purpose of this study is to collect blood samples for DNA analysis from patients clinically diagnosed with Alzheimers disease, Lewy Body disease, and ...
List of GME residency and fellowship training programs in medical genetics and genomics at Mayo Clinic School of Graduate Medical Education.
About this study. To compare with a randomized trial (n=15 per treatment group), effects of colesevelam and placebo treatment, on colonic transit, ...
The objective of Study M15-991 is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to ...
The purpose of this study is to understand the role of genetics (inherited genes from biological parents) and expression of genes and proteins in the lining of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!